Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06778902 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AZA Combined with R-GemOx for Elderly DLBCL Patients

Study acronym: Dragon
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a prospective, single-arm, multicenter, phase II clinical trial to evaluate the efficacy and safety of AZA（azacytidine）combined with the R-GemOx (rituximab, gemcitabine and oxaliplatin) regimen as first-line treatment in elderly diffuse large B-cell lymphoma (DLBCL) patients.
Trial Details
NCT Number NCT06778902
Lead Sponsor Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions
(from sponsor)		 DLBCL - Diffuse Large B Cell Lymphoma
Related terms Dendritic Cell Sarcoma, Interdigitating, Lymphoma, Large B-Cell, Diffuse
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov